Evidence map›Paper›PMID 26725122›Full record

ArticleCell reports2016

NIPBL Controls RNA Biogenesis to Prevent Activation of the Stress Kinase PKR.

Kobe C Yuen, Baoshan Xu, Ian D Krantz, Jennifer L Gerton

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. RNA recognition by PKR during DNA virus infection.Journal of medical virology · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Regulation of Antiviral Immune Response byFrontiers in microbiology · 2021
    Review
  9. The Genome-Wide Impact ofInternational journal of molecular sciences · 2020
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. NIPBLScientific reports · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kobe C YuenStowers Institute for Medical Research (SIMR), 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Baoshan XuStowers Institute for Medical Research (SIMR), 1000 East 50(th) Street, Kansas City, MO 64110, USA.
Ian D KrantzChildren's Hospital of Philadelphia, Division of Human Genetics, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Jennifer L GertonStowers Institute for Medical Research (SIMR), 1000 East 50(th) Street, Kansas City, MO 64110, USA; University of Kansas School of Medicine, Department of Biochemistry and Molecular Biology, 3901 Rainbow Boulevard, Kansas City, KS 66160, USA. Electronic address: jeg@stowers.org.
Stowers Institute for Medical Research · USChildren's Hospital of Philadelphia · USUniversity of Kansas · US

Funding

VERTEBRATE ANIMAL MODELS OF CORNELIA DE LANGE SYNDROMEP01HD052860 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI KRANTZ, IAN D. · 2006 to 2015
$11.2M
NICHD NIH HHS P01 HD052860
6 · The paper itself

Abstract

NIPBL, a cohesin loader, has been implicated in transcriptional control and genome organization. Mutations in NIPBL, cohesin, and its deacetylase HDAC8 result in Cornelia de Lange syndrome. We report activation of the RNA-sensing kinase PKR in human lymphoblastoid cell lines carrying NIPBL or HDAC8 mutations, but not SMC1A or SMC3 mutations. PKR activation can be triggered by unmodified RNAs. Gene expression profiles in NIPBL-deficient lymphoblastoid cells and mouse embryonic stem cells reveal lower expression of genes involved in RNA processing and modification. NIPBL mutant lymphoblastoid cells show reduced proliferation and protein synthesis with increased apoptosis, all of which are partially reversed by a PKR inhibitor. Non-coding RNAs from an NIPBL mutant line had less m(6)A modification and activated PKR activity in vitro. This study provides insight into the molecular pathology of Cornelia de Lange syndrome by establishing a relationship between NIPBL and HDAC8 mutations and PKR activation.

Indexed as

MutationAnimalsCell Cycle ProteinsDe Lange SyndromeeIF-2 KinaseEnzyme ActivationHistone DeacetylasesHumansMiceProteinsRepressor ProteinsRNATranscription FactorsCell Cycle ProteinseIF-2 KinaseHDAC8 protein, humanHDAC8 protein, mouseHistone DeacetylasesNIPBL protein, humanNipbl protein, mouseprotein kinase R, mouseProteinsRepressor ProteinsRNATranscription Factors

Identifiers

PMID26725122
PMCPMC4904785
OpenAlexW2217535290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.